Sonesitatug Vedotin + Rilvegostomig for adenocarcinoma

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 3 Feb 2026: Trial started, NCT07431281
  2. 24 Feb 2026: Trial registered, NCT07431281

The trials

NCT07431281: Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

State
Under way
Phase
Phase 3
People
2,130 planned
Started
3 Feb 2026
Primary completion
16 Aug 2029
Arms
Arm A
Results
None posted
  1. 3 Feb 2026: Trial started
  2. 24 Feb 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.